Medicines used to treat lifestyle illnesses are known as lifestyle drugs. These are ailments such as baldness, impotence, wrinkles, alcoholism, and smoking that are caused by our lifestyle choices. The majority of these conditions are non-life threatening and non-painful. Over-the-counter lifestyle medications can be used to alter not just one's physical and mental capacities, but also their appearance.
Viagra (sildenafil citrate), which is used to treat erectile dysfunction, is an example of a lifestyle drug. Cosmetic medications such as Latisse and Botox, energy and focus-enhancing pharmaceuticals such as Provigil (modafinil), birth control drugs such as Yaz and Levora, and smoking cessation therapies such as Zyban or Chantix are all available.
Market Dynamics for Lifestyle Drugs Around the World
Product launches and approvals are likely to accelerate the growth of the global lifestyle pharmaceuticals market. For example, Mayne Pharma announced on April 16, 2021, that the United States Food and Drug Administration (FDA) had authorized Nextstellis, a contraceptive pill containing E4, a naturally occurring estrogen with an atypical mode of action that may be more useful than other estrogens. Mayne Pharma is committed to developing novel oral drug delivery technologies in order to manufacture and sell branded generic pharmaceuticals, providing patients with better and more accessible drugs.
Regional Insights on the Global Lifestyle Drugs Market
Because of the rising incidences of obesity, North America is predicted to account for the highest share of the global Lifestyle Drugs Market over the forecast period. For example, the adult obesity rate in 2019 was 42.4 percent, according to the Centers for Disease Control and Prevention, which was likely the first time the national rate crossed the 40 percent level, demonstrating the obesity issue in the United States.
The market for Lifestyle Drugs in the United States - Competitive Landscape
Pfizer Inc, Biesterfeld Spezialchemie GmbH, Roman Inc, Sytheon Ltd., Unilever plc, Johnson & Johnson, Neutrogena Corporation, Oriflame cosmetics, Eli Lily &co, Novo Nordisk A/S, AstraZeneca plc, GlaxoSmithKline plc, and Allergan plc are among the major competitors in the worldwide lifestyle drugs market.
Market Dynamics for Lifestyle Drugs Around the World
Product launches and approvals are likely to accelerate the growth of the global lifestyle pharmaceuticals market. For example, Mayne Pharma announced on April 16, 2021, that the United States Food and Drug Administration (FDA) had authorized Nextstellis, a contraceptive pill containing E4, a naturally occurring estrogen with an atypical mode of action that may be more useful than other estrogens. Mayne Pharma is committed to developing novel oral drug delivery technologies in order to manufacture and sell branded generic pharmaceuticals, providing patients with better and more accessible drugs.
Regional Insights on the Global Lifestyle Drugs Market
Because of the rising incidences of obesity, North America is predicted to account for the highest share of the global Lifestyle Drugs Market over the forecast period. For example, the adult obesity rate in 2019 was 42.4 percent, according to the Centers for Disease Control and Prevention, which was likely the first time the national rate crossed the 40 percent level, demonstrating the obesity issue in the United States.
The market for Lifestyle Drugs in the United States - Competitive Landscape
Pfizer Inc, Biesterfeld Spezialchemie GmbH, Roman Inc, Sytheon Ltd., Unilever plc, Johnson & Johnson, Neutrogena Corporation, Oriflame cosmetics, Eli Lily &co, Novo Nordisk A/S, AstraZeneca plc, GlaxoSmithKline plc, and Allergan plc are among the major competitors in the worldwide lifestyle drugs market.
0 Comments